Early-Onset Depression Leaves a Wider Cognitive Footprint, Major Chinese Cohort Finds

Depression has never been a single illness, and one of the most consequential ways of splitting it apart may be the age at which it first strikes. A new multicenter study from China, published in BMC Psychiatry, suggests that adults whose major depressive disorder begins before the age of 30 carry a distinctly broader burden of cognitive impairment than those whose illness emerges later in adulthood — even when both groups are in their first episode and have never yet taken a psychiatric drug. The finding, drawn from 349 untreated patients and 287 healthy comparison subjects, offers clinicians a deceptively simple marker for identifying which newly diagnosed patients may need closer cognitive monitoring from the very start of care.

The research team, led by Xu Yang and Li-Min Xin of Beijing Huilongguan Hospital at Capital Medical University, together with senior author Tian-Mei Si of Peking University Sixth Hospital, recruited participants from a Chinese multicenter cohort known as ODMPIM — Objective Diagnostic Markers and Personalized Intervention in MDD Patients. The trial was registered on ClinicalTrials.gov as NCT02023567 in December 2013, and the study drew on nine psychiatric and general hospitals across China, from Peking University Sixth Hospital and Beijing Anding Hospital to sites in Tianjin, Shanxi, Hebei, Dalian and Shanxi Medical University. Ethics committees at every participating institution approved the protocol, and all participants gave written informed consent under the Declaration of Helsinki.

What makes the design unusually clean is the drug-naïve, first-episode restriction. Most studies of cognition in depression examine patients who have already been exposed to antidepressants, sometimes for years, which makes it difficult to separate the effects of the illness itself from the effects of treatment, chronicity or prior episodes. By enrolling only people who had never received psychotropic medication and were experiencing their first depressive episode, the researchers could ask a purer question: what does depression, in its untreated first appearance, actually do to the thinking brain — and does the answer depend on when in life the disorder first emerged?

The cutoff chosen was 30 years of age at onset. Patients whose depression first appeared before 30 were classified as younger-onset; those whose illness began at 30 or later were classified as older-onset. All patients completed the 17-item Hamilton Depression Rating Scale to quantify depressive severity, the Mini-International Neuropsychiatric Interview to confirm diagnosis, and the Childhood Trauma Questionnaire-Short Form to capture early adversity across emotional, physical and sexual abuse and neglect domains. Healthy controls completed the trauma questionnaire and the same cognitive battery, allowing the team to benchmark both patient subgroups against people without the disorder.

The cognitive assessment spanned five domains, each tapped by established neuropsychological instruments. Processing speed was measured with the Digit Symbol Coding Test and the Color Trial Test. Executive function was probed through the Stroop Color-Word Test and Auditory Verbal Fluency. Attention was assessed with the Continuous Performance Test-Identical Pairs, a demanding task requiring sustained vigilance to fleeting stimulus matches. Verbal learning and memory relied on the Hopkins Verbal Learning Test-Revised, while visual learning and memory used the Brief Visual Memory Test-Revised. Statistical analysis proceeded through multivariate analysis of covariance, followed by correlation and multiple linear regression models that asked which clinical variables best predicted cognitive performance.

The headline result is a stark asymmetry. Younger-onset patients showed impairments across all five cognitive domains relative to healthy controls — processing speed, attention, executive function, verbal learning and visual learning were all affected. Older-onset patients, by contrast, displayed a narrower profile, with deficits confined to processing speed, verbal learning and executive function, while their attention and visual memory performance did not differ significantly from the healthy comparison group. When the two patient subgroups were compared directly, the younger-onset group performed worse than the older-onset group specifically in processing speed and in learning on the Hopkins Verbal Learning Test-Revised, pointing to speed of mental processing and the capacity to acquire new verbal material as the domains most sensitive to early illness onset.

Equally revealing were the results that failed to materialize. Both patient subgroups reported significantly higher levels of childhood trauma than healthy controls, yet the rates of current suicidal ideation — assessed with the Mini-International Neuropsychiatric Interview — were similar between the younger- and older-onset groups. And in the regression models, neither total childhood trauma scores nor Hamilton depression severity predicted cognitive performance. This dissociation matters: it suggests that the cognitive differences between onset groups are not simply a byproduct of more severe depression or a heavier load of early adversity, but may reflect something intrinsic to the developmental timing of the disorder itself.

The regression analyses did surface other predictors. Younger age-at-onset and male sex both predicted poorer processing speed and weaker executive function, reinforcing the picture that an early-arriving illness, particularly in men, is associated with the most pronounced slowing and the greatest difficulty in flexible, goal-directed thinking. In a counterintuitive twist, the presence of suicidal ideation was associated with better processing speed. The authors frame the study as exploratory, and this association in particular invites cautious interpretation — but it hints that the cognitive signatures of depression may not map neatly onto clinical risk in straightforward ways, and that faster processing in some patients may coexist with acute psychological distress.

Why might an earlier onset leave a wider cognitive footprint? The authors’ framing points toward neurodevelopment. Cognitive abilities such as processing speed and verbal learning continue to mature through the third decade of life, and an illness that disrupts brain function during or before this window may interfere with abilities that are still consolidating, or may mark a more neurodevelopmentally rooted form of depression. A later onset, arriving after cognitive systems have fully matured, may spare some domains — attention and visual memory in this dataset — while still eroding speed, verbal learning and executive control. Age-at-onset, in other words, may act as a clinically relevant marker of cognitive heterogeneity, a way of subtyping major depressive disorder that carries direct implications for rehabilitation, occupational counseling and the monitoring of functional recovery in newly diagnosed adults.

The study’s limitations temper but do not erase its significance. The cross-sectional design captures a single moment in time and cannot establish whether early-onset patients will remain more impaired over the course of illness or treatment. The 30-year cutoff, while clinically meaningful, is ultimately a convention, and the authors describe their cognitive patterns as exploratory rather than definitive. Still, the scale of the cohort, the rigor of the five-domain battery and, above all, the drug-naïve first-episode design give the findings unusual weight. For a disorder diagnosed in hundreds of millions of people worldwide, the message is concrete: when a young adult walks into a clinic with a first episode of depression, the age at which the illness began may be one of the most informative numbers on the chart — a signal of how widely cognition has been affected, and of which patients deserve the closest attention to the thinking skills that underpin work, study and daily life.

Subject of Research: Age-at-onset differences in neurocognition, childhood trauma and suicidal ideation in drug-naïve first-episode major depressive disorder

Article Title: Neurocognition, childhood trauma and suicidal ideation in drug-naïve first-episode major depressive disorder: a comparison of younger- versus older-onset patients

Article References: Yang, X., Xin, L.-M., Fan, H.-Z., Lin, J.-Y., Yan, F., Yu, X., Su, Y.-A., & Si, T.-M. (2026). Neurocognition, childhood trauma and suicidal ideation in drug-naïve first-episode major depressive disorder: a comparison of younger- versus older-onset patients. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08695-6

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08695-6

Keywords: major depressive disorder, age-at-onset, neurocognition, childhood trauma, suicidal ideation, drug-naïve, first-episode, processing speed, executive function, verbal learning, BMC Psychiatry, multicenter cohort